These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
670 related articles for article (PubMed ID: 21439804)
1. Breath profiles by electronic nose correlate with systemic markers but not ozone response. Biller H; Holz O; Windt H; Koch W; Müller M; Jörres RA; Krug N; Hohlfeld JM Respir Med; 2011 Sep; 105(9):1352-63. PubMed ID: 21439804 [TBL] [Abstract][Full Text] [Related]
2. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445 [TBL] [Abstract][Full Text] [Related]
3. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD. Fens N; de Nijs SB; Peters S; Dekker T; Knobel HH; Vink TJ; Willard NP; Zwinderman AH; Krouwels FH; Janssen HG; Lutter R; Sterk PJ Eur Respir J; 2011 Dec; 38(6):1301-9. PubMed ID: 21700610 [TBL] [Abstract][Full Text] [Related]
4. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643 [TBL] [Abstract][Full Text] [Related]
5. External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease. Fens N; Roldaan AC; van der Schee MP; Boksem RJ; Zwinderman AH; Bel EH; Sterk PJ Clin Exp Allergy; 2011 Oct; 41(10):1371-8. PubMed ID: 21732998 [TBL] [Abstract][Full Text] [Related]
6. Discrimination between COPD patients with and without alpha 1-antitrypsin deficiency using an electronic nose. Hattesohl AD; Jörres RA; Dressel H; Schmid S; Vogelmeier C; Greulich T; Noeske S; Bals R; Koczulla AR Respirology; 2011 Nov; 16(8):1258-64. PubMed ID: 21883674 [TBL] [Abstract][Full Text] [Related]
7. Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthma. Brinkman P; van de Pol MA; Gerritsen MG; Bos LD; Dekker T; Smids BS; Sinha A; Majoor CJ; Sneeboer MM; Knobel HH; Vink TJ; de Jongh FH; Lutter R; Sterk PJ; Fens N Clin Exp Allergy; 2017 Sep; 47(9):1159-1169. PubMed ID: 28626990 [TBL] [Abstract][Full Text] [Related]
9. Nitric oxide (NO) in exhaled air after experimental ozone exposure in humans. Olin AC; Stenfors N; Torén K; Blomberg A; Helleday R; Ledin MC; Ljungkvist G; Ekman A; Sandström T Respir Med; 2001 Jun; 95(6):491-5. PubMed ID: 11421507 [TBL] [Abstract][Full Text] [Related]
10. The Influence of Smoking Status on Exhaled Breath Profiles in Asthma and COPD Patients. Principe S; van Bragt JJMH; Longo C; de Vries R; Sterk PJ; Scichilone N; Vijverberg SJH; Maitland-van der Zee AH Molecules; 2021 Mar; 26(5):. PubMed ID: 33806279 [TBL] [Abstract][Full Text] [Related]
11. Exhaled breath condensate and airway inflammation. Hoffmeyer F; Raulf-Heimsoth M; Brüning T Curr Opin Allergy Clin Immunol; 2009 Feb; 9(1):16-22. PubMed ID: 19532089 [TBL] [Abstract][Full Text] [Related]
12. [Comparison of four identical electronic noses and three measurement set-ups]. Koczulla R; Hattesohl A; Biller H; Hofbauer J; Hohlfeld J; Oeser C; Wirtz H; Jörres RA Pneumologie; 2011 Aug; 65(8):465-70. PubMed ID: 21437859 [TBL] [Abstract][Full Text] [Related]
13. Non-invasive biomarkers of pulmonary damage and inflammation: Application to children exposed to ozone and trichloramine. Bernard A; Carbonnelle S; Nickmilder M; de Burbure C Toxicol Appl Pharmacol; 2005 Aug; 206(2):185-90. PubMed ID: 15967207 [TBL] [Abstract][Full Text] [Related]
14. An electronic nose in the discrimination of patients with asthma and controls. Dragonieri S; Schot R; Mertens BJ; Le Cessie S; Gauw SA; Spanevello A; Resta O; Willard NP; Vink TJ; Rabe KF; Bel EH; Sterk PJ J Allergy Clin Immunol; 2007 Oct; 120(4):856-62. PubMed ID: 17658592 [TBL] [Abstract][Full Text] [Related]
15. Induced sputum and exhaled nitric oxide as noninvasive markers of airway inflammation from work exposures. Lemiere C Curr Opin Allergy Clin Immunol; 2007 Apr; 7(2):133-7. PubMed ID: 17351465 [TBL] [Abstract][Full Text] [Related]
16. Markers of lung disease in exhaled breath: nitric oxide. Choi J; Hoffman LA; Rodway GW; Sethi JM Biol Res Nurs; 2006 Apr; 7(4):241-55. PubMed ID: 16581895 [TBL] [Abstract][Full Text] [Related]
17. FENO measurement and sputum analysis for diagnosing asthma in clinical practice. Schneider A; Schwarzbach J; Faderl B; Welker L; Karsch-Völk M; Jörres RA Respir Med; 2013 Feb; 107(2):209-16. PubMed ID: 23107283 [TBL] [Abstract][Full Text] [Related]
18. Identifying chronic obstructive pulmonary disease and asthma by exhaled breath analysis: does the (e)Nose know? Machado RF Am J Respir Crit Care Med; 2009 Dec; 180(11):1038-9. PubMed ID: 19923400 [No Abstract] [Full Text] [Related]
19. The value of sputum 8-isoprostane in detecting oxidative stress in mild asthma. Louhelainen N; Rytilä P; Obase Y; Mäkelä M; Haahtela T; Kinnula VL; Pelkonen A J Asthma; 2008 Mar; 45(2):149-54. PubMed ID: 18350407 [TBL] [Abstract][Full Text] [Related]
20. Exhaled breath condensate as a method of sampling airway nitric oxide and other markers of inflammation. Liu J; Thomas PS Med Sci Monit; 2005 Aug; 11(8):MT53-62. PubMed ID: 16049390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]